Loading insider details...
Latest Form 4 (Nov 12, 2026): Grant/Award of 171,000 MTRI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | InMed Pharmaceuticals Inc. (MTRI) | Grant/Award | 171,000 | n/a |
| Mar 23, 2026 | Kalaris Therapeutics, Inc. (KLRS) | Sale | 1,915 | $12.9K |
| Apr 11, 2025 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 50,262 | n/a |
| Mar 27, 2025 | Kalaris Therapeutics, Inc. (KLRS) | Sale | 907 | $8.1K |
| Feb 24, 2025 | Allovir, Inc. (ALVR) | Sale | 96 | $967.28 |
| Jan 27, 2025 | Allovir, Inc. (ALVR) | Sale | 32 | $302.52 |
| Jan 13, 2025 | Allovir, Inc. (ALVR) | Sale | 332 | $146.11 |
| Nov 20, 2024 | Allovir, Inc. (ALVR) | Sale | 554 | $303.87 |
| Nov 6, 2024 | Allovir, Inc. (ALVR) | Sale | 1,655 | $1.4K |
| Oct 23, 2024 | Allovir, Inc. (ALVR) | Sale | 479 | $373.14 |